HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,571 | +117927.1% | 4,427 | +12.2% | 0.01% | +20.0% |
| Q2 2023 | $336 | -34.9% | 3,946 | -36.7% | 0.01% | +11.1% |
| Q1 2023 | $516 | +16.2% | 6,234 | +10.5% | 0.01% | -47.1% |
| Q4 2022 | $444 | -99.9% | 5,642 | +5.8% | 0.02% | +6.2% |
| Q3 2022 | $395,000 | -6.6% | 5,333 | -17.8% | 0.02% | +6.7% |
| Q2 2022 | $423,000 | -6.2% | 6,490 | -9.1% | 0.02% | +15.4% |
| Q1 2022 | $451,000 | – | 7,137 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |